| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3923278 | European Urology | 2008 | 11 Pages |
Abstract
Forty percent of septa- and octogenarian men who are selected for RP do not have adequate life expectancy to warrant attempted curative therapy. Even more strikingly, 70% of men who receive EBRT die before reaching the 10-yr mark. These findings may indicate the need for more stringent EBRT and RP selection criteria, if the goal is to minimise overtreatment.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Claudio Jeldres, Nazareno Suardi, Jochen Walz, Fred Saad, Georg C. Hutterer, Naeem Bhojani, Shahrokh F. Shariat, Paul Perrotte, Markus Graefen, Francesco Montorsi, Pierre I. Karakiewicz,